Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
VHL Antibody, Elongin binding protein Antibody, HRCA1 Antibody, RCA1 Antibody, VHL1 Antibody, Von Hippel-Lindau syndrome Antibody, Protein G7 Antibody, PVHL Antibody
Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity.
Detection of VHL in human kidney samples (30 ug). ECL detection 10 seconds. Lane 1:0.5 ug/ml primary Lane 2:2 ug/ml primary. This image was taken for the unconjugated form of this product. Other forms have not been tested.